C. Congy

发表

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

P. Soubrié, P. Ferrara, D. Caput, 1994, FEBS letters.

Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist.

P. Soubrié, M. Héaulme, M. Rinaldi-Carmona, 1995, Life sciences.

Up-regulation of 5-HT2 receptors in the rat brain by repeated administration of SR 46349B, a selective 5-HT2 receptor antagonist.

J. Simiand, P. Soubrié, P. Casellas, 1993, European journal of pharmacology.

Identification of binding sites for SR 46349B, a 5-hydroxytryptamine2 receptor antagonist, in rodent brain.

G. Fur, M. Rinaldi-Carmona, C. Congy, 1994, Life sciences.

carboxamide ] , a New Potent and Selective Antagonist of the CB 1 Cannabinoid Receptor : Biochemical and Pharmacological Characterization

P. Soubrié, M. Poncelet, G. Fur, 2004 .

SR147778, A NEW POTENT AND SELECTIVE ANTAGONIST OF THE CB1 CANNABINOID RECEPTOR. BIOCHEMICAL AND PHARMACOLOGICAL CHARACTERIZATION

M. Poncelet, J. Maruani, F. Barth, 2004 .

SR147778 [5-(4-Bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a New Potent and Selective Antagonist of the CB1 Cannabinoid Receptor: Biochemical and Pharmacological Characterization

P. Soubrié, M. Poncelet, J. Maruani, 2004, Journal of Pharmacology and Experimental Therapeutics.

Derivatives of 1,5-diarylpyrrole, their preparation and their therapeutic application

F. Barth, C. Congy, C. Rinaldi, 2005 .

SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.

P. Casellas, G. Fur, M. Rinaldi-Carmona, 1998, The Journal of pharmacology and experimental therapeutics.

Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain.

P. Soubrié, G. Fur, M. Rinaldi-Carmona, 1996, Life sciences.

Rational design of a novel peripherally-restricted, orally active CB(1) cannabinoid antagonist containing a 2,3-diarylpyrrole motif.

M. Rinaldi-Carmona, F. Barth, C. Congy, 2010, Bioorganic & medicinal chemistry letters.

Repeated administration of SR 46349B, a selective 5-hydroxytryptamine2 antagonist, up-regulates 5-hydroxytryptamine2 receptors in mouse brain.

J. Simiand, P. Soubrié, F. Oury-Donat, 1993, Molecular pharmacology.

Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist.

J. Simiand, P. Soubrié, M. Rinaldi-Carmona, 1992, The Journal of pharmacology and experimental therapeutics.